BrightSpring Health Services Reports Strong Q4 & FY25 Results, Issues Positive FY26 Guidance
BTSG has more than doubled off its 52-week low of $15.484.
Summary
BrightSpring Health Services reported strong fourth quarter and full year 2025 financial results, showcasing significant revenue and profit growth, a substantial increase in operating cash flow, and improved leverage, alongside positive guidance for 2026.
Key Events · Earnings and Guidance · BTSG
-
Strong Q4 and Full Year 2025 Results
Reported a 29.3% increase in Q4 net revenue to $3.55 billion and a 28.2% increase in full year net revenue to $12.91 billion. Adjusted EBITDA grew 40.7% in Q4 and 34.2% for the full year.
-
Significant Profitability Turnaround
Achieved a net income of $49.6 million in Q4 and $104.8 million for the full year 2025, reversing a net loss of $68.9 million in 2024.
-
Substantial Operating Cash Flow & Improved Leverage
Operating cash flow for 2025 surged to $490 million, a significant increase from $24 million in 2024. The company also reduced its leverage ratio to 2.99x.
-
Positive Full Year 2026 Guidance
Provided guidance for 2026 revenues of $14.45 billion to $15.00 billion (11.9% to 16.2% growth) and Adjusted EBITDA of $760 million to $790 million (23.1% to 27.9% growth).
Analysis · BTSG · Industrial Applications And Services
BrightSpring Health Services delivered robust financial performance for both the fourth quarter and full year 2025, marked by significant revenue and Adjusted EBITDA growth. Notably, the company achieved a substantial turnaround from a net loss in 2024 to a net income of $104.8 million for the full year 2025, alongside a massive increase in operating cash flow. The improved leverage ratio further strengthens its financial position. The positive full-year 2026 guidance, projecting continued strong growth in revenue and Adjusted EBITDA, indicates management's confidence in the company's operational trajectory. The share repurchase also signals a commitment to shareholder value. These results are likely to reinforce investor confidence, especially as the stock trades near its 52-week high.
At the time of this filing, BTSG was trading at $40.60 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $7.2B. The 52-week trading range was $15.48 to $41.40. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.